Skip to content
Search AI Powered

Latest Stories

RPS launches new programme to enhance pharmacists' prescribing skills

RPS launches new programme to enhance pharmacists' prescribing skills

It aims to equip pharmacists with the essential knowledge, skills, and confidence to diagnose and treat common conditions and minor ailments

The Royal Pharmaceutical Society (RPS) has introduced a new comprehensive learning programme to support pharmacists in Wales to deliver the Pharmacy Independent Prescribing Service (PIPS).


Developed in collaboration with Health Education and Improvement Wales (HEIW), the programme is designed to “equip pharmacists with the essential knowledge, skills, and confidence needed to provide excellent patient care.”

While the primary emphasis is on pharmacists operating within primary care settings, those from various practice settings are also encouraged to register and participate in the programme.

Commenting on the collaboration with HEIW, Elen Jones, director for Wales at the Royal Pharmaceutical Society, said that it will empower pharmacists across the country to deliver high-quality prescribing services to local communities.

“By equipping pharmacists with the knowledge, skills, and confidence to treat specific conditions as prescribers, we are not only enhancing the quality of patient care but also strengthening the role of pharmacists as vital members of the healthcare team,” she added.

The programme has been designed by pharmacists from the RPS education and professional development team, with the content for each session being written by practising pharmacist prescribers or general practitioners.

Each session will explore conditions commonly encountered in community pharmacy practice.

Acknowledging the contribution of prescribing pharmacists in Wales, Jones said: “Through collaboration with Community Pharmacy Wales, feedback was obtained which has ensured its relevance and effectiveness in meeting the professional development needs of pharmacists,” Jones said.

“The programme's focus on common conditions and minor ailments aligns perfectly with the everyday challenges faced by pharmacists in their practice,” she added.

Margaret Allan, Pharmacy Dean at Health Education and Improvement Wales, reiterated HEIW’s commitment to developing education and training for the pharmacy workforce, aligning with the objectives of Pharmacy: Delivering a Healthier Wales.

“Through our collaboration with the RPS on this series of events for pharmacist independent prescribers, we hope to improve confidence in prescribing and equity of access to the provision of the PIPS across Wales,” Allan said.

Key features of the programme

Under this programme, participants will learn to diagnose common conditions and minor ailments, identify red flag symptoms, know when and how to refer patients to other healthcare services, and treat common conditions and minor ailments.

The sessions will be presented as six separate two-hour workshops, incorporating presentations, knowledge quizzes, group activities, case study discussions, and Q&A sessions with experts.

The in-person workshops will be organised across North Wales, Mid and West Wales, and South Wales.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less